ZURICH, May 23 (Reuters) - Novartis NOVN.S has 25 potential blockbuster treatments in development, the company said ahead of a management event in the United States on Thursday.
"Our pipeline is industry-leading with more than 25 potential blockbusters and this pace of innovation positions Novartis well for the future", said Novartis Chief Executive Vas Narasimhan in a statement.
(Reporting by Silke Koltrowitz)
((silke.koltrowitz@thomsonreuters.com; +41 58 306 7454; Reuters Messaging: silke.koltrowitz.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.